Lawrentschuk N - Search Results

1

Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.

See AW, Bowden P, Wells G, Appu S, Lawrentschuk N, Liodakis P, Pandeli C, Aarons Y, Smyth LML, McKenzie DP. See AW, et al. Among authors: lawrentschuk n. Radiat Oncol. 2022 Jul 25;17(1):131. doi: 10.1186/s13014-022-02103-5. Radiat Oncol. 2022. PMID: 35879722 Free PMC article. Clinical Trial.

2

Effectiveness of cyproterone acetate in achieving castration and preventing luteinizing hormone releasing hormone analogue induced testosterone surge in patients with prostate cancer.

Appu S, Lawrentschuk N, Grills RJ, Neerhut G. Appu S, et al. Among authors: lawrentschuk n. J Urol. 2005 Jul;174(1):140-2. doi: 10.1097/01.ju.0000161591.86721.e5. J Urol. 2005. PMID: 15947599 Clinical Trial.

3

Peritoneal "pillowcase" for the displaced spleen post-distal pancreatectomy.

Appu S, Young AB, Lawrentschuk N. Appu S, et al. Among authors: lawrentschuk n. J Hepatobiliary Pancreat Surg. 2005;12(6):470-3. doi: 10.1007/s00534-005-1011-2. J Hepatobiliary Pancreat Surg. 2005. PMID: 16365821

4

Metachronous metastasis to the penis from carcinoma of the rectum.

Appu S, Lawrentschuk N, Russell JM, Bright NF. Appu S, et al. Among authors: lawrentschuk n. Int J Urol. 2006 May;13(5):659-61. doi: 10.1111/j.1442-2042.2006.01379.x. Int J Urol. 2006. PMID: 16771752

5

Peripheral primitive neuroectodermal tumor arising from the seminal vesicle.

Lawrentschuk N, Appu S, Chao I, Chan Y, Rogerson J, Davis ID. Lawrentschuk N, et al. Urol Int. 2008;80(2):212-5; discussion 216. doi: 10.1159/000112616. Epub 2008 Mar 19. Urol Int. 2008. PMID: 18362495

6

Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.

Satasivam P, Reeves F, Rao K, Ivey Z, Basto M, Yip M, Roth H, Grummet J, Goad J, Moon D, Murphy D, Appu S, Lawrentschuk N, Bolton D, Kearsley J, Costello A, Frydenberg M. Satasivam P, et al. Among authors: lawrentschuk n. BJU Int. 2015 Oct;116(4):590-5. doi: 10.1111/bju.13075. Epub 2015 Mar 30. BJU Int. 2015. PMID: 25676543

7

Brachytherapy: state-of-the-art radiotherapy in prostate cancer.

Chao MW, Grimm P, Yaxley J, Jagavkar R, Ng M, Lawrentschuk N. Chao MW, et al. Among authors: lawrentschuk n. BJU Int. 2015 Oct;116 Suppl 3:80-8. doi: 10.1111/bju.13252. BJU Int. 2015. PMID: 26260701 Review. No abstract available.

8

The role of cystectomy in elderly patients - a multicentre analysis.

Izquierdo L, Peri L, Leon P, Ramírez-Backhaus M, Manning T, Alcaraz A, Roupret M, Solsona E, Rubio J, Sengupta S, Chan Y, Liodakis P, Gyomber D, Bolton D, Lawrentschuk N. Izquierdo L, et al. Among authors: lawrentschuk n. BJU Int. 2015 Oct;116 Suppl 3:73-9. doi: 10.1111/bju.13227. Epub 2015 Sep 2. BJU Int. 2015. PMID: 26333289

9

Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial.

Siva S, Pham D, Kron T, Bressel M, Lam J, Tan TH, Chesson B, Shaw M, Chander S, Gill S, Brook NR, Lawrentschuk N, Murphy DG, Foroudi F. Siva S, et al. Among authors: lawrentschuk n. BJU Int. 2017 Nov;120(5):623-630. doi: 10.1111/bju.13811. Epub 2017 Mar 10. BJU Int. 2017. PMID: 28188682 Clinical Trial.

10

Trends in the surgical treatment of benign prostatic hyperplasia in a tertiary hospital.

Ow D, Papa N, Perera M, Liodakis P, Sengupta S, Clarke S, Bolton DM, Lawrentschuk N. Ow D, et al. Among authors: lawrentschuk n. ANZ J Surg. 2018 Jan;88(1-2):95-99. doi: 10.1111/ans.13904. Epub 2017 Mar 19. ANZ J Surg. 2018. PMID: 28317227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

597 results

Search Page